Hess KR - Search Results

1

Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis.

Sano T, Lin H, Chen X, Langford LA, Koul D, Bondy ML, Hess KR, Myers JN, Hong YK, Yung WK, Steck PA. Sano T, et al. Among authors: hess kr. Cancer Res. 1999 Apr 15;59(8):1820-4. Cancer Res. 1999. PMID: 10213484

2

Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme.

Ritter AM, Sawaya R, Hess KR, Levin VA, Bruner JM. Ritter AM, et al. Among authors: hess kr. Neurosurgery. 1994 Aug;35(2):192-8; discussion 198. doi: 10.1227/00006123-199408000-00003. Neurosurgery. 1994. PMID: 7969825

3

Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.

Vassilopoulou-Sellin R, Guinee VF, Klein MJ, Taylor SH, Hess KR, Schultz PN, Samaan NA. Vassilopoulou-Sellin R, et al. Among authors: hess kr. Cancer. 1993 May 15;71(10):3119-23. doi: 10.1002/1097-0142(19930515)71:10<3119::aid-cncr2820711037>3.0.co;2-8. Cancer. 1993. PMID: 8490842

4

TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.

Kaba SE, Kyritsis AP, Hess K, Yung WK, Mercier R, Dakhil S, Jaeckle KA, Levin VA. Kaba SE, et al. J Clin Oncol. 1997 Mar;15(3):1063-70. doi: 10.1200/JCO.1997.15.3.1063. J Clin Oncol. 1997. PMID: 9060546 Clinical Trial.

5

Correlation between dynamic MRI and outcome in patients with malignant gliomas.

Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, Jaeckle KA, Yung WK, Levin VA, Leeds NE. Wong ET, et al. Among authors: hess kr. Neurology. 1998 Mar;50(3):777-81. doi: 10.1212/wnl.50.3.777. Neurology. 1998. PMID: 9521274

6

Assessing response to chemotherapy in malignant glioma: the role of steroids.

Hess KR, Wong ET, Yung WK. Hess KR, et al. Neurology. 1998 Apr;50(4):1197; disscussion 1197-8. doi: 10.1212/wnl.50.4.1197. Neurology. 1998. PMID: 9566439 No abstract available.

7

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA. Lin H, et al. Among authors: hess kr. Clin Cancer Res. 1998 Oct;4(10):2447-54. Clin Cancer Res. 1998. PMID: 9796977

8

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.

Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR, Skibber JM. Spitz FR, et al. Among authors: hess k. Clin Cancer Res. 1997 Oct;3(10):1685-90. Clin Cancer Res. 1997. PMID: 9815551

9

Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.

Ali-Osman F, Brunner JM, Kutluk TM, Hess K. Ali-Osman F, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2253-61. Clin Cancer Res. 1997. PMID: 9815622

10

Prognostic significance of p53 immunoreactivity in patients with glioma.

Kyritsis AP, Bondy ML, Hess KR, Cunningham JE, Zhu D, Amos CJ, Yung WK, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: hess kr. Clin Cancer Res. 1995 Dec;1(12):1617-22. Clin Cancer Res. 1995. PMID: 9815964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters